Please assess the completion status of the following clinical trial:

Trial Title: Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ARDS with a PaO2 / FiO2 \< 150 with a PEEP \> 5 since less than 48 hrs~* informed consent~Exclusion Criteria:~* NMBA allergy~* Continuous administration of NMBA for ARDS prior inclusion~* Age \< 18 yrs~* SAPS II \> 70~* Persistent air leak

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: PLACEBO_COMPARATOR): None
- B (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).